Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

John B. Ketchum

At a glance: John B. Ketchum is Director at Tango Therapeutics (TNGX). Their latest SEC Form 4, filed Nov 19, 2026, reported a sale of $80K. On file: 0 purchase lines ($0) and 1 sale line ($80K).

Disclosed holdings: about $492K of TNGX stock: 21,604 shares reported on their latest Form 4 (filed Nov 19, 2026), valued at the Nov 19, 2026 close of $22.77. This counts only TNGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Tango Therapeutics, Inc. (TNGX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $80K

Reported trades

Filed Stock Type Shares Price Value Since
Nov 19SEC TNGXTango Therapeutics, Inc. Sell Plan 3,33321,604 held (−13%) $24.08 $80K -5.4%
  • Sell

    Director John B Ketchum sold $80K of TNGX at $24.08 — pre-scheduled 10b5-1 plan sale.

Follow John B. Ketchum

Get one email when John B. Ketchum files a new purchase or sale. Free.

At most one email a day about John B. Ketchum, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.